Recombinant vaccines against bluetongue virus
Open Access
- 1 March 2014
- journal article
- review article
- Published by Elsevier in Virus Research
- Vol. 182, 78-86
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Multiserotype Protection Elicited by a Combinatorial Prime-Boost Vaccination Strategy against Bluetongue VirusPLOS ONE, 2012
- Experimental oral infection of bluetongue virus serotype 8 in type I interferon receptor-deficient miceJournal of General Virology, 2010
- Heterologous prime boost vaccination with DNA and recombinant modified vaccinia virus Ankara protects IFNAR(−/−) mice against lethal bluetongue infectionVaccine, 2009
- Establishment of a Bluetongue Virus Infection Model in Mice that Are Deficient in the Alpha/Beta Interferon ReceptorPLOS ONE, 2009
- A European field strain of bluetongue virus derived from two parental vaccine strains by genome segment reassortmentVirus Research, 2008
- Development of Reverse Genetics Systems for Bluetongue Virus: Recovery of Infectious Virus from Synthetic RNA TranscriptsJournal of Virology, 2008
- Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheepVaccine, 2007
- Tumor Regression Induced by Intratumor Therapy with a Disabled Infectious Single Cycle (DISC) Herpes Simplex Virus (HSV) Vector, DISC/HSV/Murine Granulocyte-Macrophage Colony-Stimulating Factor, Correlates with Antigen-Specific Adaptive ImmunityThe Journal of Immunology, 2002
- Antigen specificity of the ovine cytotoxic T lymphocyte response to bluetongue virusVeterinary Immunology and Immunopathology, 1995
- Response of the regional lymph node to bluetongue virus infection in calvesVeterinary Immunology and Immunopathology, 1995